What DR. BÄHLER DROPA does

DR. BÄHLER DROPA AG is a privately held, family-owned Swiss healthcare services company founded in 1967 in Steffisburg by pharmacist couple Giulia and Werner Bähler, with headquarters now at Binzstrasse 38, Zürich. It operates an integrated retail, franchise, and institutional medication-management business across approximately 120 locations in German-speaking Switzerland, employing roughly 2,000 staff including more than 300 apprentices, and reporting under no public ticker (CHE-109.103.351). The portfolio is organized into three operating units: Apotheken & Drogerien Dr. Bähler (company-owned pharmacies and drugstores under the Achillea brand), DROPA Drogerien Apotheken (a franchised network combining ~40 owned locations with ~40 independent franchise partners), and the Schweizer Blisterzentrum — a Swissmedic-certified cleanroom facility operating the most modern fully-automated GMP-compliant blister packaging production line in Switzerland, which produces patient-individualized medication sachets for nursing homes, Spitex home-care organizations, prisons, assisted-living facilities, individual patients, and external pharmacies outside the DBD network. The company runs a structured pharmaceutical training pipeline (Drogist*in and Fachfrau/Fachmann Apotheke apprenticeships, Famulatur, Assistenzstellen, and the Trainee@DBD postgraduate program) producing licensed pharmacists and druggists in a market where pharmacist-licensed dispensing is mandatory. Leadership is anchored by the founding family: Franklin Schatzmann as Chair of the Executive Board, Sandra Schatzmann-Bähler (member of the executive board, head of HR development, daughter of the founders), and Marcel Bähler (location manager), supported by departmental heads for marketing and finance. The company operates without disclosed venture capital, private equity, or public market backing.

Name

DR. BÄHLER DROPA

Legal name

DR. BÄHLER DROPA AG

Website

https://baehlerdropa.ch

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

501–1,000 employees

Short description

DR. BÄHLER DROPA AG is a family-owned Swiss pharmacy and drugstore operator running approximately 120 locations across German-speaking Switzerland through owned (Achillea), franchise (DROPA), and institutional medication-blister-packaging (Schweizer Blisterzentrum) units, serving retail consumers, nursing homes, Spitex organizations, correctional facilities, and external pharmacies.

Ownership category

akta.pro rank

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Retail Pharmacy and Drugstore Sales: Revenue from direct operation of pharmacies and drugstores selling medications, health products, beauty products, and wellness items to end consumers. Company operates approximately 80 owned locations under Achillea and DROPA brands.
2. Franchise Fees and Royalties: Franchise revenue from approximately 40 DROPA franchise partners who pay fees for brand access, centralized services, purchasing power, marketing support, and operational guidance.
3. Blister Packaging Services: Fee-for-service revenue from patient-individualized medication blister packaging provided to nursing homes, Spitex organizations, prisons, assisted living facilities, and individual patients, as well as external pharmacies outside the DBD network.
4. Institutional Medical Supplies: Supply of pharmaceuticals, nursing supplies, and consumables to institutions including nursing homes and Spitex organizations, including billing to insurance providers.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

DR. BÄHLER DROPA AG operates a network of approximately 120 pharmacies and drugstores across German-speaking Switzerland under the owned Achillea brand and the DROPA franchise brand, alongside the Schweizer Blisterzentrum which produces patient-individualized medication blister packaging in a Swissmedic-certified cleanroom. The company also delivers institutional pharmaceutical supply, blister packaging, and consulting services to nursing homes, Spitex organizations, prisons, assisted living facilities, and external pharmacies, supported by centralized purchasing, HR, quality assurance, marketing, and management services.

Product overview

DR. BÄHLER DROPA AG operates as a Swiss healthcare services company consisting of three interconnected business units: (1) Apotheken & Drogerien Dr. Bähler (own-brand pharmacies and drugstores under the Achillea brand), (2) DROPA Drogerien Apotheken (franchise network with both owned and independent partner locations), and (3) Schweizer Blisterzentrum (individualized medication blister packaging service). The company also provides institutional care solutions for retirement homes and Spitex organizations, and offers comprehensive training programs including apprenticeships (Fachfrau/Fachmann Apotheke, Drogist*in), pharmacy internships (Famulatur, Assistenzzeit), and the Trainee@DBD professional development program. A central service center in Zürich provides administrative, HR, procurement, quality assurance, marketing, and management support to all network locations. The network encompasses approximately 120 locations across German-speaking Switzerland.

Differentiator

Problem solved

Functional benefit

Brands

• Schweizer Blisterzentrum: Patient-individual medication blister packaging service for institutions and patients, with GMP-certified production facility.

Products and services

• Apotheken & Drogerien Dr. Bähler (Achillea) Company-owned pharmacies and drugstores operating under the Achillea brand (white 'A' in green circle logo), run as independent profit centers with autonomous operational decisions by location managers. Aimed at end consumers seeking pharmacy products, drugstore items, beauty, wellness, and pharmaceutical advice.
• DROPA Drogerien Apotheken DROPA franchise network of drugstores and pharmacies combining company-owned locations with independent franchise partners who benefit from the DROPA brand, purchasing power, marketing support, and centralized services. Franchise partners are typically licensed Apotheker*innen and Drogist*innen HF.
• Schweizer Blisterzentrum Patient-individualized medication blister packaging service producing individually portioned medications in the most modern GMP-compliant production facility in Switzerland, operating from a Swissmedic-certified cleanroom with fully automated lines and photographic quality control. Serves nursing homes, Spitex organizations, prisons, assisted living facilities, individual patients, and external pharmacies outside the DBD network.
• Institutional Care Solutions Comprehensive services for institutional care customers covering pharmaceutical supply, consumables procurement, consultancy, and quality management support. Served via direct sales to nursing homes (Alters- und Pflegeheime) and Spitex organizations for medication delivery, patient-specific dosing, and supply logistics.
• Franchising & Nachfolge Franchising and succession planning services for drugstores and pharmacies, including the Franchising-Start-up program that supports entrepreneurs (Apotheker*innen and Drogist*innen HF) without established businesses with startup capital, know-how, and initial-phase operational support under the DROPA brand.

Quantifiable outcome

• 97% apprenticeship exam pass rate with 18 podium placements (2025)
• +2 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

Feature3 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Swissmedic (Swiss Agency for Therapeutic Products)coreStrategic or Co-development PartnerSwissmedic certification for the Schweizer Blisterzentrum cleanroom facility, ensuring compliance with Swiss pharmaceutical manufacturing standards (GMP). Working processes are Swissmedic certified for medication blister packaging production.
• Choose Your Impact (Swiss pharmacy industry initiative)minorGTM or Marketing PartnerIndustry partnership promoting pharmacy professions and career opportunities in Swiss healthcare. DBD participates in this initiative to attract talent to pharmacy careers.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Amavita SA: Amavita is one of Switzerland's largest pharmacy chains with over 180 locations, directly comparable to DBD's network of ~120 stores. It is part of Galenicare (formerly Galexis pharmacy division) and competes head-to-head in the same Swiss retail pharmacy market.
• Medbase AG: Medbase is a Swiss healthcare network combining medical centers, pharmacies, and physiotherapy, with locations concentrated in German-speaking Switzerland. Comparable to DBD's institutional care and integrated retail offerings.
• TopPharm AG: TopPharm is a cooperative-style network of independent Swiss pharmacies with ~120 member locations, a peer to DBD in that it combines a brand, purchasing, and marketing platform with independently operated pharmacies.
• Sun Store SA: Sun Store is another major Swiss pharmacy chain, historically part of the Galenica group, operating discount-format pharmacies across Switzerland. It competes directly with DBD in the retail pharmacy space.
• Well Apotheke (formerly Schlecker/Well): Well is a Swiss pharmacy chain with locations across the country, part of the same retail pharmacy market. It is a direct comparable to DBD's owned and franchise pharmacy formats.
• Müller Drogeriemärkte (Müller Holding): Müller operates drugstore and perfumery retail locations in Switzerland, directly comparable to DBD's drugstore (Drogerie) offerings. The two compete in the health, beauty, and wellness retail segment.

Broad incumbents

• BENU Apotheken (Phoenix Group): BENU is a major European pharmacy chain brand with Swiss locations, part of the German Phoenix Group. It competes with DBD in Swiss retail pharmacy and brings broader European scale.
• Galenicare AG: Galenicare is the umbrella organization of major Swiss pharmacy chains (Amavita, Sun Store, Coop Vitality), and a division of Galenica. Comparable to DBD at a parent/group level as one of the leading pharmacy retail platform operators in Switzerland.

Others

• Pharmaprix (Shoppers Drug Mart / Loblaw): Pharmaprix is a major Canadian pharmacy chain under Loblaw, not a direct Swiss competitor but illustrative of a scaled pharmacy retail platform that compares to DBD in format, services, and institutional partnerships. Included as a thematically related peer for retail pharmacy scale.

Emerging players

• DocMorris AG (formerly Zur Rose): DocMorris is a leading online pharmacy and mail-order pharmaceutical platform based in Switzerland, serving the same Swiss end market as DBD but via a different (digital) channel. It is the primary digital disruptor to traditional chains like DBD.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/baehlerdropa

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DR. BÄHLER DROPA